A major percentage of world population is affected by neurological disorders, this in turn is causing major disabilities globally. Due to the high incidence of neurological disorders, there is the need for biomarkers as biomarkers measure biological states and are used for indication of both pathogenic as well as normal biological process in terms of therapeutic intervention. Biomarkers can also be utilized in combination for accessing the state of the disease of an individual.
This report contains market size and forecasts of Nervous System Markers in global, including the following market information:
Global Nervous System Markers Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Nervous System Markers Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Nervous System Markers companies in 2021 (%)
The global Nervous System Markers market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Imaging Biomarkers Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nervous System Markers include Athena Diagnostics, Myriad RBM, AbaStar MDx, QIAGEN and Thermo Fisher Scientific, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nervous System Markers manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nervous System Markers Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nervous System Markers Market Segment Percentages, by Type, 2021 (%)
Imaging Biomarkers
Metabolomics Biomarkers
Proteomic Biomarkers
Genomics Biomarkers
Global Nervous System Markers Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nervous System Markers Market Segment Percentages, by Application, 2021 (%)
Spinal Muscular Atrophy (SMA)
Multiple Sclerosis
Depression
Schizophrenia
Huntington's Disease
Parkinson's Disease
Alzheimer's Disease
Global Nervous System Markers Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nervous System Markers Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nervous System Markers revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Nervous System Markers revenues share in global market, 2021 (%)
Key companies Nervous System Markers sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Nervous System Markers sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Athena Diagnostics
Myriad RBM
AbaStar MDx
QIAGEN
Thermo Fisher Scientific